Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannascribe is a Canadian medical cannabis access and prescription-support company operating as a clinic and patient services business rather than a drug developer. The company helps patients obtain legal access to medical cannabis, connect with practitioners, and navigate Canadian medical cannabis regulations and licensed producer options. Public business-directory and clinic listings indicate that Cannascribe has operated since 2014 and serves patients across Ontario, including the Greater Toronto Area. The federal corporate entity appears to have been incorporated as Cannascribe, Inc. and later renamed Synergy Health Rx Corp. in 2024 while the Cannascribe brand remains in market use. There is no evidence that Cannascribe develops proprietary therapeutic products or runs a conventional biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannascribe.